Dedicada a la Infección Nosocomial, efectos adversos de medicamentos, efectos adversos postanestésicos, etc.

,

World Alliance Against Antibiotic Resistance. Alliance Contre le développement des Bactéries Multi-Résistantes. The WAAAR declaration against antibiotic resistance

cronica

The increase in antibiotic resistant bacteria poses a major healthcare threat. In the face of an almost complete absence of new antimicrobial drugs in development, antibiotic resistance (ABR) has become one of the main public health problems of our time. Antibiotics are a unique class of medications because of their potential societal impact; use of an antibiotic in a single patient can select for ABR that can spread to other people, animals, and the environment, making an antibacterial used in one patient ineffective for many others.

Leer artículo completo: DECLARATION-WAAAR[1]

,

CDC: Criterios de infecciones 2014 y novedades con respecto a la infección del sitio quirúrgico.

CDC

Se adjuntan los criterios de infecciones 2014 y las novedades con respecto a la infección del sitio quirúrgico.

17pscNosInfDef_current

CDC SSI

 

,

ANTIBIOTIC RESISTANCE THREATS in the United States, 2013

tomAntimicrobial resistance is one of our most serious health threats. Infections from resistant bacteria are now too common, and some pathogens have even become resistant to multiple types or classes of antibiotics (antimicrobials used to treat bacterial infections). The loss of effective antibiotics will undermine our ability to fight infectious diseases and manage the infectious complications common in vulnerable patients undergoing chemotherapy for cancer, dialysis for renal failure, and surgery, especially organ transplantation, for which the ability to treat secondary infections is crucial.
When first-line and then second-line antibiotic treatment options are limited by resistance or are unavailable, healthcare providers are forced to use antibiotics that may be more toxic to the patient and frequently more expensive and less effective. Even when alternative treatments exist, research has shown that patients with resistant infections are often much more likely to die, and survivors have significantly longer hospital stays, delayed recuperation, and long-term disability. Efforts to prevent such threats build on the foundation of proven public health strategies: immunization, infection control, protecting the food supply, antibiotic stewardship, and reducing person-to-person spread through screening, treatment and education.

Dr. Tom Frieden, MD, MPH
Director, U.S. Centers for Disease Control and Prevention
Meeting the Challenges of Drug-Resistant Diseases in Developing Countries
Committee on Foreign Affairs Subcommittee on Africa, Global Health, Human Rights,
and International Organizations
United States House of Representatives
April 23, 2013

ANTIBIOTIC RESISTANCE THREATS in the United States, 2013

,

Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011–2012

 ECDC_logo

Cada día, al menos 1 de cada 18 pacientes sufre una infección adquirida tras su paso por el hospital, lo que cada año supone que, de media, alrededor de 3,2 millones de personas se vean afectadas por sus consecuencias, según una encuesta llevada a cabo por el Centro Europeo para la Prevención y el Control de las Enfermedades. Las estimaciones apuntan que, en un día determinado, alrededor de 80.000 pacientes en los hospitales europeos tienen al menos una infección asociada.

Las autoridades recomiendan un aumento de la vigilancia de las infecciones a nivel local, nacional y europeo, y mejorar la sensibilización sobre el posible desarrollo de infecciones asociadas por contacto en los profesionales sanitarios. Además, han incidido también en la necesidad de luchar contra las resistencias a los antimicrobianos.

Resultados EPINE-EPPS 2012 Resumen (v1_1)

,

A comprehensive evidence review narrows the field of targets to prevent harm. These are things hospitals should be doing to protect patients.

Segur_pacienteA panel of experts, several of whom spoke with American Medical News, worked for more than three years to produce a 955-page Agency for Healthcare Research and Quality report that for the first time in a decade comprehensively reviews the effectiveness of more than 100 patient safety interventions. The panel identified 10 strategies that are “strongly encouraged.”

The report, published in March, recommends that most health care organizations implement these interventions within the next three years. Current use of these practices varies widely depending on the safety strategy, but the report's authors say it is clear that implementation is far from universal.

Leer más